Mayo Internet Ephedra Study Finds Misleading Claims Rampant
This article was originally published in The Tan Sheet
Executive Summary
More than half the websites touting ephedra weight loss products fail to list appropriate dosages of the botanical, according to a study in August's Mayo Clinic Proceedings
You may also be interested in...
Ephedrine Alkaloid Supplements Not “Imminent Hazard,” Metabolife Says
The FD&C Act's "imminent hazard" provision does not give HHS the authority to immediately ban ephedrine alkaloid-containing dietary supplements, Metabolife says
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands